Patents Assigned to CHR. Hansen
  • Patent number: 11856970
    Abstract: Described are the Bacillus subtilis strain deposited as DSM 32685 and mutant strains thereof which are susceptible to relevant antibiotics, have inhibitory activity against, for example, Staphylococcus, Streptococcus, E. coli and Salmonella, and have the ability to facilitate degradation of non-starch polysaccharides and thereby increase the amount of available oligosaccharides (sugar) in animal feed. Also described are compositions comprising at least one Bacillus subtilis strain of the disclosure and optionally further bacteria and/or one or more types of yeast and methods of using such compositions.
    Type: Grant
    Filed: January 18, 2019
    Date of Patent: January 2, 2024
    Assignee: Chr. Hansen A/S
    Inventors: Dorthe Sandvang, Ole Knudsmark Sjoeholm, Line Skjoet-Rasmussen, Jette Mundus Nielsen
  • Publication number: 20230416673
    Abstract: The present invention relates to a novel Streptococcus thermophilus strain having improved texturizing properties, compositions comprising said strain as well as fermented products manufactured using said strain.
    Type: Application
    Filed: November 16, 2021
    Publication date: December 28, 2023
    Applicant: Chr. Hansen A/S
    Inventors: Kim Ib Soerensen, Mette Pia Junge, Jesper Broend, Victoria Prebner
  • Publication number: 20230399669
    Abstract: Disclosed are genetically engineered microbial cells for the production of oligosaccharides comprising a galactose-?1,4-glucose moiety at their reducing end, wherein said microbial cells are able to produce said oligosaccharides in the absence of exogenously added lactose, and a method of producing said oligosaccharides using said microbial cells.
    Type: Application
    Filed: June 8, 2023
    Publication date: December 14, 2023
    Applicant: Chr. Hansen HMO GmbH
    Inventors: Stefan Jennewein, Dirk Wartenberg, Katja Parschat
  • Patent number: 11834691
    Abstract: The present invention describes an efficient way to isolate a sialic acid from a fermentation broth. The sialic acid contained in the fermentation broth is produced by bacterial fermentation. The inventive process comprises a step of removing biomass from the fermentation broth, a step of subjecting the resulting solution to at least one of a cationic ion exchanger treatment and an anionic ion exchanger treatment and a step of removing salts after the ion exchanger treatment. The process can provide the sialic acid in spray-dried form as well as in form of sialic acid crystals.
    Type: Grant
    Filed: October 31, 2018
    Date of Patent: December 5, 2023
    Assignee: Chr. Hansen HMO GmbH
    Inventors: Stefan Jennewein, Markus Helfrich
  • Patent number: 11827913
    Abstract: Variants of chymosin with improved milk-clotting properties are disclosed.
    Type: Grant
    Filed: January 7, 2022
    Date of Patent: November 28, 2023
    Assignee: Chr. Hansen A/S
    Inventors: Johannes Maarten Van Den Brink, Jesper Langholm Jensen, Jonas Jacobsen, Martin Lund, Iben Jeppesen, Christian Jaeckel
  • Publication number: 20230341182
    Abstract: The present disclosure relates to a process for electrostatic spray drying of a living microorganism, the process comprising the following steps: a. Providing a suspension, comprising a number of components, including a microorganism, a solvent and an additive; b. Applying an electrostatic charge to said suspension; c. Forming droplets of said suspension; d. Drying said droplets, thereby forming dried particles; and e. (Optionally) collecting the dried particles.
    Type: Application
    Filed: January 29, 2021
    Publication date: October 26, 2023
    Applicant: Chr. Hansen A/S
    Inventors: Jimi Kjaersgaard Pettersson, Wendy Ossieur, Michelle Milling Madsen, Kim Nielsen
  • Publication number: 20230329264
    Abstract: The present invention relates to a high temperature resistant Lactobacillus delbrueckii subsp. lactis DSM 32009 strain that can be used in the production of cheese where the curd is cooked at high temperature (>50° C.).
    Type: Application
    Filed: February 27, 2023
    Publication date: October 19, 2023
    Applicant: Chr. Hansen A/S
    Inventors: Gaelle Lettier Buchhorn, Dina Vanell, Kim Ib Soerensen, Gunnar Oeregaard, Annette Kibenich, Per Stroeman
  • Publication number: 20230323332
    Abstract: The present invention relates to microencapsulated microbial cultures with high storage stability and methods for producing these. In particular, the present invention relates to microbial cultures formulated in complex coacervates comprising octenyl succinic anhydride (OSA) starch and chitosan, products comprising such formulations.
    Type: Application
    Filed: August 20, 2021
    Publication date: October 12, 2023
    Applicant: Chr. Hansen A/S
    Inventors: Pravin Vasant Gadkari, Furqan Ali, Surender Kumar Dhayal
  • Publication number: 20230304052
    Abstract: Disclosed are genetically-engineered gram-negative bacterial cells for the production of an oligosaccharide of interest, wherein the bacterial cell possesses a saccharide transporter and/or a porin being expressed from a recombinant gene or a deregulated endogenous gene, thereby facilitating the translocation of the oligosaccharide of interest from the cell's cytoplasm into the cell's environment. Also disclosed are methods for producing an oligosaccharide of interest which used said genetically-engineered gram-negative bacterial cells.
    Type: Application
    Filed: June 11, 2021
    Publication date: September 28, 2023
    Applicant: Chr. Hansen HMO GmbH
    Inventors: Markus Englert, Stefan Jennewein, Henning Frerigmann, Katja Parschat, Christian Trötschel
  • Publication number: 20230292780
    Abstract: The present invention is in the field of food technology. The present invention provides methods of controlling growth of Listeria by limiting their access to manganese More specifically, the present invention provides a method of inhibiting or delaying growth of Listeria by reducing the manganese concentration in a food product which is preferably a dairy product. The invention also provides manganese scavengers and uses thereof to inhibit or delay Listeria growth.
    Type: Application
    Filed: April 16, 2021
    Publication date: September 21, 2023
    Applicant: Chr. Hansen A/S
    Inventors: Lieke VAN GIJTENBEEK, Solvej SIEDLER, Helle Skov GULDAGER, Louise Essendrup STEFFENSEN
  • Publication number: 20230292779
    Abstract: The present invention relates to compositions and methods for producing continental cheese in a non-wash process.
    Type: Application
    Filed: May 28, 2021
    Publication date: September 21, 2023
    Applicant: Chr. Hansen A/S
    Inventors: Mia Ryssel, Thomas Baek Pedersen, Peter Beierholm Poulsen, Sebastien Roustel
  • Patent number: 11758914
    Abstract: The present invention is directed to a method of producing a Streptococcus thermophilus strain comprising the steps of a) Providing a mother strain in the form of Streptococcus thermophilus DSM32502, b) Growing a culture of the mother strain in the presence of a bacteriophage, to which the mother strain is not resistant, to obtain a number of mutant strains, which are resistant to the said bacteriophage, c) Measuring the acidification time of the bacteriophage-resistant mutant strains and the mother strain in a milk base and selecting at least one mutant strain with a reduced acidification time as compared to the mother strain to obtain a fast-acidifying mutant strain.
    Type: Grant
    Filed: December 22, 2022
    Date of Patent: September 19, 2023
    Assignee: Chr. Hansen A/S
    Inventors: Jeorgos Trihaas, Thomas Janzen, Patrick Derkx
  • Patent number: 11744259
    Abstract: The present invention relates to a method of producing a fermented milk product comprising adding lactic acid bacteria to milk, wherein the bacteria comprise Lactobacillus casei and at least one further strain of lactic acid bacteria of a species other than Lactobacillus casei, wherein the further strain has a deficiency in lactose metabolism but is capable of metabolizing one or several carbohydrates other than lactose present in the milk.
    Type: Grant
    Filed: January 23, 2017
    Date of Patent: September 5, 2023
    Assignee: Chr. Hansen A/S
    Inventors: Mirjana Curic-Bawden, Luciana Luciana Jimenez, Mette Oehrstroem Runge, Karen Guillotte, Pia Frost Jensen
  • Publication number: 20230271992
    Abstract: Provided is a method for the purification of lacto-N-neotetraose from other carbohydrates, characterized in that the method comprises the steps of subjecting an aqueous solution containing lacto-N-neotetraose to two membrane filtration steps using different membranes or of subjecting an aqueous solution containing lacto-N-neotetraose to a membrane filtration step and a continuous chromatography.
    Type: Application
    Filed: May 10, 2023
    Publication date: August 31, 2023
    Applicant: Chr. Hansen HMO GmbH
    Inventors: Stefan Jennewein, Markus Helfrich
  • Publication number: 20230270140
    Abstract: A betalain pigment composition from red beet plants including pre-harvest foliar spraying of an ethylene-generating compound and the use of the obtained betalain pigment composition for coloring of an edible product
    Type: Application
    Filed: May 10, 2023
    Publication date: August 31, 2023
    Applicants: CHR. HANSEN NATURAL COLORS A/S, UNIVERSITY OF COPENHAGEN
    Inventors: Gregorio Barba ESPIN, Henrik Vlk LUETKEN, Bjarne JOERNSGAARD, Renate Petra Brigitte MUELLER, Tsaneta DZHANFEZOVA, Stephan GLIED, Bjoern MADSEN
  • Patent number: 11732282
    Abstract: The present invention concerns an efficient way to isolate L-fucose from a fermentation broth. The L-fucose contained in the fermentation broth is produced by microbial fermentation (bacterial or yeasts). The inventive process comprises a step of removing biomass from the fermentation broth, a step of subjecting the resulting solution to at least one of a cationic ion exchanger treatment and an anionic ion exchanger treatment and a step of removing salts after the ion exchanger treatment. The process can provide L-fucose in powder form, in granulated form as well as in form of L-fucose crystals.
    Type: Grant
    Filed: November 15, 2018
    Date of Patent: August 22, 2023
    Assignee: Chr. Hansen HMO GmbH
    Inventors: Markus Helfrich, Stefan Jennewein
  • Patent number: 11723378
    Abstract: The present invention relates to a composition suitable for preparing a dairy product comprising at least one starter culture and a Lactobacillus rhamnosus strain capable of imparting onto the dairy product an enhanced creamy flavor without affecting the rheology negatively, the fermentation time or the post-acidification of the dairy product. The present invention further relates to processes for preparing a dairy product, such as a low-fat yogurt or cheese, which has a high content of diacetyl. A Lactobacillus rhamnosus strain useful for preparing such dairy product is also part of the present invention.
    Type: Grant
    Filed: November 22, 2021
    Date of Patent: August 15, 2023
    Assignee: Chr. Hansen A/S
    Inventors: Stina Dissing Aunsbjerg Nielsen, Helle Skov Guldager, Cecilie Lykke Marvig Nielsen
  • Publication number: 20230240310
    Abstract: The invention relates to preparation of fermented food products, including dairy or dairy analogue products, with Pichia kluyveri and lactic acid bacteria in the presence of carbohydrate(s) which is sucrose, fructose, glucose or mixtures thereof. Fermentation of such products can be made using a starter culture composition comprising Pichia kluyveri strain(s) and lactic acid bacteria strain(s). The composition optionally comprises carbohydrate(s) which is sucrose, fructose and/or glucose.
    Type: Application
    Filed: June 30, 2021
    Publication date: August 3, 2023
    Applicant: Chr. Hansen A/S
    Inventors: Patrizia Buldo, Raquel Fernandez, Kasui Tang, Kristian Fog Nielsen, Asger Geppel
  • Patent number: 11713475
    Abstract: Disclosed are genetically engineered microbial cells for the production of oligosaccharides comprising a galactose-?1,4-glucose moiety at their reducing end, wherein said microbial cells are able to produce said oligosaccharides in the absence of exogenously added lactose, and a method of producing said oligosaccharides using said microbial cells.
    Type: Grant
    Filed: September 2, 2019
    Date of Patent: August 1, 2023
    Assignee: Chr. Hansen HMO GmbH
    Inventors: Stefan Jennewein, Dirk Wartenberg, Katja Parschat
  • Publication number: 20230232851
    Abstract: The present invention is in the field of dairy technology. It relates to methods of inhibiting Listeria in dairy products, characterized in that the fermentation is carried out using Lactobacillus rhamnosus DSM 32092 or a mutant thereof. The invention also provides use of Lactobacillus rhamnosus DSM 32092 to inhibit Listeria and dairy products comprising Lactobacillus rhamnosus DSM 32092 such as cheeses.
    Type: Application
    Filed: April 16, 2021
    Publication date: July 27, 2023
    Applicant: Chr. Hansen A/S
    Inventors: Mikkel Gulmann Madsen, Helle Skov Guldager, Louise Essendrup Steffensen, Shannon Neuens, Anja Kristiansen, Cecilie Lykke Marvig Nielsen, Dana Wolle